Results 231 to 240 of about 1,425,061 (397)

Clinical Significance of Copper Chaperone for Superoxide Dismutase in Colorectal Cancer

Annals of Gastroenterological Surgery, EarlyView.
ABSTRACT Background Targeting Cu transport proteins is an innovative therapeutic approach for combating cancer. However, the mechanisms underlying the malignant potential of Cu transport proteins remain largely unknown. To address this issue, we focused on the oncogenic potential of copper chaperones for superoxide dismutase (CCS) in colorectal cancer (
Nobuo Takiguchi, Mamoru Uemura, Mao Osaki, Chikako Kusunoki, Masakatsu Paku, Mitsunobu Takeda, Yuki Sekido, Tsuyoshi Hata, Atsushi Hamabe, Takayuki Ogino, Norikatsu Miyoshi, Mitsuyoshi Tei, Yoshinori Kagawa, Hirofumi Yamamoto, Yuichiro Doki, Hidetoshi Eguchi   +15 more
wiley   +1 more source

Adjuvant Chemotherapy and Immunotherapy in Upper Tract Urothelial Carcinoma: Where Do We Stand? [PDF]

Cancers (Basel)
Carbunaru S, Rich JM, Murray KS.
europepmc   +1 more source

Postoperative Impact of Anti‐Inflammatory Drug on Cancer Recurrence in Patients With Locally Advanced Gastric Cancer After Curative Gastrectomy: A Pilot Retrospective Study

Annals of Gastroenterological Surgery, EarlyView.
Anti‐inflammatory drugs may be effective in improving recurrence‐free survival after radical gastrectomy in patients with pStage II or III gastric cancer. ABSTRACT Background Elevated postoperative inflammation is associated with reduced recurrence‐free survival (RFS) after gastrectomy in patients with gastric cancer, independent of postoperative ...
Ryota Matsui, Manabu Ohashi, Motonari Ri, Rie Makuuchi, Masaru Hayami, Tomoyuki Irino, Takeshi Sano, Souya Nunobe   +7 more
wiley   +1 more source

Risk of second primary malignancies after adjuvant chemotherapy for colon cancer. [PDF]

Cancer
Buchler T, Ambrozova M, Majek O, Dianova T, Klika P, Dusek L.   +5 more
europepmc   +1 more source

Association of Delayed Adjuvant Chemotherapy With Survival After Lung Cancer Surgery

JAMA Oncology, 2017
Michelle C Salazar, J. Rosen, Zuoheng Wang, Brian N. Arnold, Daniel C. Thomas, R. Herbst, A. Kim, F. Detterbeck, J. Blasberg, D. Boffa   +9 more
semanticscholar   +1 more source

Prognostic Impact of Immunoscore in Pathological Stage III Differentiated Gastric Cancer: A Multicenter Cohort Study Including PD‐L1/PD‐L2 Expression Analysis

Annals of Gastroenterological Surgery, EarlyView.
We assessed the prognostic ability of the Immunoscore and PD‐L1 or PD‐L2 expression in pStage III GC patients by immunohistochemistry. The results showed that Immunoscore was an independent prognostic factor in differentiated GC, but not in undifferentiated GC.
Yoshiro Yukawa, Takuro Saito, Yukinori Kurokawa, Yusuke Akamaru, Shinya Kidogami, Hiroshi Imamura, Kazumasa Fujitani, Jin Matsuyama, Kazuyoshi Yamamoto, Tsuyoshi Takahashi, Takahiro Matsui, Eiichi Morii, Hidetoshi Eguchi, Yuichiro Doki   +13 more
wiley   +1 more source

Does different surgical approaches affect tolerance to postoperative adjuvant chemotherapy in early-stage upper gastric cancer? [PDF]

Front Surg
Zuo S, Zhang Y, Liao X.
europepmc   +1 more source

Adjuvant Chemotherapy for Stage II Colon Cancer: A Clinical Dilemma.

Journal of Oncology Practice, 2017
Joseph Kannarkatt, Joe Joseph, P. Kurniali, A. Al-Janadi, B. Hrinczenko   +4 more
semanticscholar   +1 more source

Influence of Hospital and Surgeon Volumes on Clinical Outcomes After Standard Surgery for Advanced Gastric Cancer: Supplementary Analysis of the Multicenter Randomized Phase III Trial JCOG1001

Annals of Gastroenterological Surgery, EarlyView.
We have evaluated interinstitutional variation to verify the generalization and standardization of gastric cancer surgery from a supplementary analysis of the randomized phase III trial JCOG1001. Although there was some degree of interinstitutional variation in short‐ and long‐term outcomes after standard gastric surgery, we found no correlation ...
Motohiro Hirao, Yukinori Kurokawa, Riku Kajikawa, Junki Mizusawa, Kota Kawabata, Masanori Tokunaga, Kenji Kuroda, Shinichi Sakuramoto, Itaru Yasufuku, Hisayuki Matsushita, Shuji Takiguchi, Yuichiro Doki, Takaki Yoshikawa, Masanori Terashima, Stomach Cancer Study Group of Japan Clinical Oncology Group   +14 more
wiley   +1 more source

Survival outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer patients. [PDF]

Oncologist
Wang C, Zhang J, Chen J, Zhang X, Zhang S, Zhang P, Li J.   +6 more
europepmc   +1 more source